Latest News
Uniseed invests in ResusRight, a medical device created to revolutionise neonatal resuscitation
Sydney, Australia - Uniseed, the venture fund for commercialising research from Australia's leading research organisations, announced today its investment in ResusRight, a spin-out company from the University of Sydney and Western Sydney Local Health District...
Uniseed invests in indigenous technology to make high tech medical gels from Australian spinifex grass
Brisbane, 21 February 2023 – Uniseed managed funds and Bulugudu have agreed to invest $1.3 million each ($2.6m in total) into Trioda Wilingi, a University of Queensland/UniQuest spin out company, to develop innovative medical gels from cellulose nanofibres...
Ground-breaking results in Phase 2 scleroderma study by Uniseed investee Certa Therapeutics demonstrates improvement in more than 60% of patients
Data from Certa Therapeutics’ Phase 2 clinical trial with development candidate FT011 demonstrates clinically meaningful improvements for more than 60 percent of patients with scleroderma after 12 weeks of treatment; Clinically meaningful...
Howden and Hydrexia sign MoU to accelerate the APAC hydrogen mobility sector
Wednesday, 01 February 2023 - Howden signs a Memorandum of Understanding (MoU) with Hydrexia, a market leader in Hydrogen Refuelling Stations (HRS) system design. Howden and Hydrexia have signed a cooperation agreement focused on streamlining mobility...
Survey demonstrates that individuals with COPD seek more options to reduce risks of seasonal respiratory viral infections
-- ENA Respiratory and COPD Foundation survey confirms patients are overwhelmingly positive about taking an immune-modulating nasal spray to reduce lung disease exacerbations-- -- Survey was conducted through COPD360Net®, an innovative COPD Foundation...
Ferronova secures A$11 million to advance nanotech image-guided cancer therapy
23 January 2023 - Uniseed investee Ferronova announced today it has secured a further A$11 million to progress the company’s nanoparticle platform to assist surgeons to more accurately locate and remove malignant cells during treatment of gastrointestinal and...
Uniseed Investee Company ENA Respiratory Awarded $4.38 Million U.S. Department of Defense Agreement to Fund Development of Broad-Spectrum Antiviral INNA-051
-- Goal is to add new medical countermeasure (MCM) against known and emerging viral respiratory threats Melbourne, Australia, 9th January 2023 – Clinical-stage pharmaceutical company ENA Respiratory has been awarded a $4.38 million USD agreement from...
Certa Therapeutics’ investigational drug FT011 delivers breakthrough results as a potential novel treatment for serious inflammatory and fibrotic diseases
Research presented today by University of Michigan Medical School highlights FT011’s ground-breaking treatment potential from human expression profiles in chronic kidney disease study supported by animal model data The research demonstrated that...
Uniseed invests in Tiny Bright Things (TBT), a light microscopy technology to image and measure at any scale
Melbourne, 3 November 2022 – Uniseed has led a $1.5M investment round in the Australian microscopy products company Tiny Bright Things (TBT) to transform the way researchers and manufacturers see and measure tiny or transparent objects....
Uniseed invests in University of Queensland Quantum Computing Technology company, Analog Quantum Circuits.
Brisbane, 11 October 2022 - Uniseed has committed $3M to an investment in Australian quantum technology company Analog Quantum Circuits (AQC) to fund the development of key components required for the scale up of quantum...